Profound Medical (PROF) said Friday that it priced an underwritten public offering of about 4.7 million common shares at $7.50 per share to raise gross proceeds of about $35 million.

The company granted the underwriters a 30-day option to purchase up to an additional 700,005 common shares at the same offering price.

Profound Medical expects to close the offering on or about Tuesday and said proceeds will be used to fund the commercialization of its Tulsa-Pro and Sonalleve systems and for general working capital.

Price: 8.03, Change: -0.16, Percent Change: -1.95